Our Work - Cases and information

Evidências - Kantar Health studies are cited by international guidelines

Clinical guidelines are invaluable instruments to support the daily practice of physicians and healthcare teams. National and international entities collect the best available scientific information on a specific theme and develop documents that point the most ...

Read more

Local expertise paired with global real-world research capabilities

Combined expertise presents extended capabilities Through Evidências, Kantar Health offers expanded capabilities to our clients interested in the Latin American market, leveraging local Brazilian experts when conducting clinical and ...

Read more

Systematic literature reviews global access to local databases

Evidências, a Kantar Health company, has published more than 100 SLRs and has extensive experience in developing optimal search strategies. An example of our expertise includes searching for clinical trials in the LILAC S database ...

Read more

Mapping healthcare in Brazil the lay of the land

In an industry driven by research, accurate and reliable healthcare data is essential to success. The healthcare sector in Brazil has little accurate data available regarding the epidemiology of diseases or resource use and distribution in all ...

Read more

Finding the Right Combination

Overcoming Research Challenges for a New Medicine In business, many factors come into play when searching for the right combination of assets, components or ingredients. That’s also true for pharmaceutical products, especially in oncology, where finding a winning ...

Read more

Let’s Get Personal

HTA Demonstrates Therapy’s Effectiveness for Select Patients While “one size fits all” was once the preferred method for choosing a treatment, it’s no longer appropriate in today’s age of personalized medicine, where some medicines and therapies are simply ...

Read more

Time is of the essence - especially in patient care

For oncology patients around the world, access to effective new therapies is a key factor for the successful treatment of their diseases. Expediting time to market, once safety and efficacy are demonstrated, is critical for both patients and pharmaceutical ...

Read more

Second look proves successful

They say a second look can be game changing. That’s especially true for a top-15 pharmaceutical maker in Brazil that successfully challenged a Category II pricing designation for its new oral diabetes medicine thanks to a second look by Kantar Health’s ...

Read more

Surviving a knock-out blow

The ability to get up off the canvas after a perceived knock-out blow is a sign of greatness. What makes greatness easier to achieve for pharmaceutical companies is having a world-class coach in their corner. Click here to read this case.

Read more

Considerations of building patient flow and patient forecast models in Brazil

Knowing how patients move through various treatment stages can enable improved accuracy and effectiveness in decision making. At Kantar Health/Evidências’ recent Brazil Pharmaceutical Forecasting Workshop, we explored the impact patient flow and ...

Read more

National Health and Wellness Survey

Patient-Reported Outcomes in Brazil Kantar Health’s National Health and Wellness Survey (NHWS) is the largest international self-reported patient database in the healthcare industry. The survey features unsurpassed breadth and depth of ...

Read more